Volume 8, Number 5—May 2002
Research
Sentinel Surveillance: A Reliable Way To Track Antibiotic Resistance in Communities?
Table 1
Area | Labs with >10 isolates (total labs) | Actual %PNSP | Total isolates | Percent of sentinel groups within 5 percentage points of actual %PNSP |
||
---|---|---|---|---|---|---|
3 labs (no. of groups; overall range in %PNSP) | 4 labs (no. of groups; overall range in %PNSP) | 5 labs (no. of groups; overall range in %PNSP) | ||||
CA | 5 (9) | 15 | 181 | 100 (10; 12-17) | 100 (5; 13-16) | 100 (1; NA) |
CT | 25 (32) | 18 | 681 | 73 (2,300; 2-31) | 81 (12,650;4-30) | 87 (53,130;6-30) |
GA | 18 (34) | 33 | 860 | 45 (816; 19-51) | 52 (3,060; 20-49) | 58 (8,568; 21-48) |
MD | 20 (26) | 22 | 579 | 60 (1,140; 8-40) | 68 (4,845; 9-38) | 74 (15,504; 10-37) |
MN | 12 (24) | 20 | 470 | 78 (220; 11-30) | 88 (495; 12-29) | 94 (792; 14-28) |
NY | 5 (19) | 15 | 191 | 80 (10; 9-15) | 100 (5; 10-14) | 100 (1; NA) |
OR | 6 (13) | 21 | 228 | 80 (20; 14-25) | 93 (15; 14-23) | 100 (6; 17-21) |
TN | 20 (30) | 35 | 419 | 37 (1,140; 11-62) | 40 (4,845; 13-59) | 44 (15,504;14-57) |
aIn Active Bacterial Core surveillance areas.
%PNSP, percent of penicillin-nonsusceptible invasive pneumococcal isolates.
Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.